| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer. | J Natl Cancer Inst | 2003 | 3.77 |
| 2 | Recurrence of breast cancer in the donor site after latissimus dorsi flap. | Plast Reconstr Surg | 2003 | 1.39 |
| 3 | FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients. | BMC Cancer | 2014 | 0.80 |